Jaffetilchin Investment Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $994K | Buy |
+40,822
| New | +$994K | 0.07% | 183 |
|
|
2024
Q4 | – | Sell |
-1,427
| Closed | -$36.5K | – | 429 |
|
|
2024
Q3 | $36.5K | Buy |
+1,427
| New | +$36.5K | ﹤0.01% | 627 |
|
|
2023
Q2 | – | Sell |
-12,916
| Closed | -$388K | – | 359 |
|
|
2023
Q1 | $388K | Sell |
12,916
-505
| -4% | -$15.2K | 0.04% | 244 |
|
|
2022
Q4 | $379K | Sell |
13,421
-1,056
| -7% | -$29.8K | 0.05% | 233 |
|
|
2022
Q3 | $476K | Sell |
14,477
-516
| -3% | -$17K | 0.06% | 181 |
|
|
2022
Q2 | $472K | Sell |
14,993
-598
| -4% | -$18.8K | 0.06% | 187 |
|
|
2022
Q1 | $460K | Sell |
15,591
-17,031
| -52% | -$502K | 0.05% | 195 |
|
|
2021
Q4 | $2M | Sell |
32,622
-19,273
| -37% | -$1.18M | 0.19% | 84 |
|
|
2021
Q3 | $3.88M | Buy |
51,895
+2,605
| +5% | +$195K | 0.41% | 46 |
|
|
2021
Q2 | $4.56M | Buy |
49,290
+4,740
| +11% | +$438K | 0.31% | 58 |
|
|
2021
Q1 | $3.95M | Buy |
44,550
+13,102
| +42% | +$1.16M | 0.47% | 44 |
|
|
2020
Q4 | $2.93M | Sell |
31,448
-4,339
| -12% | -$405K | 0.42% | 36 |
|
|
2020
Q3 | $2.28M | Sell |
35,787
-7,940
| -18% | -$506K | 0.42% | 40 |
|
|
2020
Q2 | $2.28M | Buy |
43,727
+24,831
| +131% | +$1.3M | 0.5% | 35 |
|
|
2020
Q1 | $591K | Buy |
+18,896
| New | +$591K | 0.21% | 72 |
|